Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v10.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (48808)
CDC/NIH Web Information Database (32264)
CDC-Authored Genomics and Precision Health Publications Database (6327)
Precision Health Database (64287)
Pathogen Advanced Molecular Detection Database (27766)
All of Us Reports and Publications Database (1018)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (232220)
Epigenetic Epidemiology Publications Database (23733)
Release Note
Contact Us
CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC-Authored Genomics and Precision Health Publications Database
Last data update: Sep 30, 2024
. (Total: 6327 publications)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
Filtered By:
Select to fine-tune your search
Year
Journal
Records 1-15 (of 15 Records)
Query Trace:
Britton A[original query]
Select gut microbiota impede rotavirus vaccine efficacy
Ngo VL , Wang Y , Wang Y ,
Shi Z
,
Britton R
,
Zou J , Ramani S ,
Jiang B
,
Gewirtz AT .
Cell Mol Gastroenterol Hepatol 2024 101393
Evaluating immunologic and illness outcomes of SARS-CoV-2 infection in vaccinated and unvaccinated children aged ≥ 5 years, in a multisite longitudinal cohort
Porter C , Lyski ZL , Uhrlaub JL , Ellingson KD , Jeddy Z , Gwynn L , Rivers P , Sprissler R , Hegmann KT ,
Coughlin MM
,
Fowlkes AL
,
Hollister J , LeClair L ,
Mak J
,
Beitel SC , Fuller S , Zheng PQ , Vaughan M , Rai RP ,
Grant L
,
Newes-Adeyi G ,
Yoo YM
,
Olsho L , Burgess JL , Caban-Martinez AJ , Yoon SK ,
Britton A
,
Gaglani M , Phillips AL , Thiese MS ,
Hagen MB
,
Jones JM
,
Lutrick K .
Diseases 2024 12 (8)
Effectiveness of bivalent mRNA COVID-19 vaccines in preventing SARS-cov-2 infection in children and adolescents aged 5 to 17 years
Feldstein LR
,
Britton A
,
Grant L
,
Wiegand R
,
Ruffin J
,
Babu TM ,
Briggs Hagen M
,
Burgess JL , Caban-Martinez AJ , Chu HY , Ellingson KD , Englund JA , Hegmann KT , Jeddy Z , Lauring AS , Lutrick K , Martin ET , Mathenge C , Meece J ,
Midgley CM
,
Monto AS , Newes-Adeyi G , Odame-Bamfo L , Olsho LEW , Phillips AL , Rai RP ,
Saydah S
,
Smith N ,
Steinhardt L
,
Tyner H , Vandermeer M , Vaughan M , Yoon SK , Gaglani M , Naleway AL .
Jama 2024 331 (5) 408-416
Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024
Link-Gelles R
,
Ciesla AA
,
Mak J
,
Miller JD
,
Silk BJ
,
Lambrou AS
,
Paden CR
,
Shirk P
,
Britton A
,
Smith ZR
,
Fleming-Dutra KE
.
MMWR Morb Mortal Wkly Rep 2024 73 (4) 77-83
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Link-Gelles R
,
Britton A
,
Fleming-Dutra KE
.
Vaccine 2023
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023
Plumb ID
,
Briggs Hagen M
,
Wiegand R
,
Dumyati G , Myers C , Harland KK , Krishnadasan A ,
James Gist J
,
Abedi G
,
Fleming-Dutra KE
,
Chea N
,
Lee JE , Kellogg M , Edmundson A , Britton A , Wilson LE , Lovett SA , Ocampo V , Markus TM , Smithline HA , Hou PC , Lee LC , Mower W , Rwamwejo F , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Eucker S , Femling J , Fuller M , Rothman RE , Curlin ME , Talan DA , Mohr NM .
Vaccine 2023
Humoral immune response to messenger RNA coronavirus disease 2019 vaccination among children aged 5-11 years in a multisite prospective cohort study, September 2021-September 2022
Lyski ZL , Porter C , Uhrlaub JL , Ellingson KD , Jeddy Z , Gwynn L , Rivers P , Sprissler R , Hegmann KT ,
Coughlin M
,
Fowlkes A
,
Hollister J , LeClair L ,
Mak J
,
Beitel SC , Fuller S ,
Grant L
,
Newes-Adeyi G ,
Yoo YM
,
Olsho L , Burgess JL , Caban-Martinez A , Yoon S ,
Britton A
,
Gaglani M , Lutrick K .
Open Forum Infect Dis 2023 10 (8) ofad431
Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged 6 months - United States, April 2023
Moulia DL
,
Wallace M
,
Roper LE
,
Godfrey M
,
Rosenblum HG
,
Link-Gelles R
,
Britton A
,
Daley MF ,
Meyer S
,
Fleming-Dutra KE
,
Oliver SE
,
Twentyman E
.
MMWR Morb Mortal Wkly Rep 2023 72 (24) 657-662
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome coronavirus 2 infection in children, adolescents, and adults during omicron subvariant BA.2/BA.2.12.1 and BA.4/BA.5 predominant periods
Ciesla AA
,
Wiegand RE
,
Smith ZR
,
Britton A
,
Fleming-Dutra KE
,
Miller J
,
Accorsi EK
,
Verani JR
,
Shang N
,
Derado G
,
Pilishvili T
,
Link-Gelles R
.
Open Forum Infect Dis 2023 10 (5) ofad187
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R
,
Ciesla AA
,
Roper LE
,
Scobie HM
,
Ali AR
,
Miller JD
,
Wiegand RE
,
Accorsi EK
,
Verani JR
,
Shang N
,
Derado G
,
Britton A
,
Smith ZR
,
Fleming-Dutra KE
.
MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
Britton A
,
Embi PJ , Levy ME , Gaglani M , DeSilva MB , Dixon BE , Dascomb K , Patel P , Schrader KE , Klein NP , Ong TC , Natarajan K , Hartmann E , Kharbanda AB , Irving SA , Dickerson M , Dunne MM , Raiyani C , Grannis SJ , Stenehjem E , Zerbo O , Rao S , Han J , Sloan-Aagard C ,
Griggs EP
,
Weber ZA , Murthy K , Fadel WF , Grisel N , McEvoy C , Lewis N , Barron MA , Nanez J , Reese SE , Mamawala M , Valvi NR , Arndorfer J , Goddard K , Yang DH , Fireman B , Ball SW , Link-Gelles R , Naleway AL ,
Tenforde MW
.
MMWR Morb Mortal Wkly Rep 2022 71 (42) 1335-1342
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE
,
Britton A
,
Shang N
,
Derado G
,
Link-Gelles R
,
Accorsi EK
,
Smith ZR
,
Miller J
,
Verani JR
,
Schrag SJ
.
JAMA 2022 327 (22) 2210-2219
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A
,
Fleming-Dutra KE
,
Shang N
,
Smith ZR
,
Dorji T
,
Derado G
,
Accorsi EK
,
Ajani UA
,
Miller J
,
Schrag SJ
,
Verani JR
.
JAMA 2022 327 (11) 1032-1041
Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats.
Strickland BA ,
Patel MC
,
Shilts MH , Boone HH , Kamali A , Zhang W , Stylos D , Boukhvalova MS , Rosas-Salazar C , Yooseph S , Rajagopala SV , Blanco JCG , Das SR .
Anim Microbiome 2021 3 (1) 29
Expanding the malaria molecular diagnostic options: opportunities and challenges for loop-mediated isothermal amplification tests for malaria control and elimination.
Lucchi NW
,
Ndiaye D , Britton S ,
Udhayakumar V
.
Expert Rev Mol Diagn 2018 18 (2) 195-203
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP